Atomoxetine 40 mg (Atomoxetine (Atomoxetine Hydrochloride) CAPSULE) 40 MG

Atomoxetine 40 mg capsules are a selective norepinephrine reuptake inhibitor (SNRI) used to manage ADHD symptoms. This medication is available in a 40 mg strength and is manufactured by Sivem Pharmaceuticals in Canada.

Strength

40 MG

Pack Size

Manufacturer / TM Owner

SIVEM PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atomoxetine is primarily used to treat attention deficit hyperactivity disorder (ADHD). It works by affecting certain chemicals in the brain that contribute to impulse control and hyperactivity. This medication is often prescribed to improve focus, reduce impulsivity, and manage symptoms associated with ADHD.

Side Effects

Common effects of Atomoxetine may include stomach upset, decreased appetite, nausea, and dizziness. Some individuals may experience dry mouth, fatigue, or insomnia. These effects can vary and are not experienced by everyone who takes the medication.

Precautions & Warnings

Atomoxetine should be handled with care, especially for individuals with a history of heart problems, high blood pressure, or glaucoma. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Keep the capsules out of reach of children and store them as directed.

Avoid Interactions

Atomoxetine may interact with certain medications, including MAO inhibitors, antidepressants, and drugs that affect blood pressure. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider.

Frequently Asked Questions

Atomoxetine is used to manage symptoms of attention deficit hyperactivity disorder (ADHD).

Atomoxetine capsules are taken orally, typically once or twice a day as directed by a healthcare provider.

Common side effects may include stomach upset, decreased appetite, nausea, and dizziness.

Atomoxetine may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Atomoxetine is often prescribed for children with ADHD, but its use should be supervised by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.